Title: Seat at the Strategy Table, 1p.

CBI’s Pharmaceutical Compliance Congress recently convened a diverse and insightful panel to reflect on the state of the compliance role within the pharmaceutical industry. There were several key messages—all invariably leading back to the challenges and opportunities of securing an effective place at a drug corporation’s executive table. Unlike the dog who one day catches the car, this goal is not about the chase. The prize here is of utmost importance: the opportunity to build and maintain company value and reputation with key stakeholders, including patients, investors, regulators, and employees; no small task and no small reward. This is, in essence, a corporation’s business case for quality—which compliance is a part of. Quality has been defined by many in different ways. Often times when someone says “quality,” others think “compliance.” But there is a difference.

Click Here For Complete Abstract Text


   Person Information
   Application Sequencing
Company  Product  Process  Other  Subjects  Event  Event  Date  Location  Publication  Publication  Date Text  Descriptor

  • Quality Assurance


  • Regulation / Standard




  • PharmaExec.com


  • 7/1/2018


  • Abstract